Whole-body diffusion-weighted imaging in lymphoma

The current evidence regarding the usefulness of whole-body diffusion-weighted magnetic resonance imaging (DWI) in lymphoma is reviewed. DWI is capable of combining anatomical and functional information and is becoming a valuable tool in oncology, in particular for staging purposes. DWI may prove to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, C., Itti, E., Luciani, A., Haioun, C., Meignan, M., Rahmouni, A.
Formato: Texto
Lenguaje:English
Publicado: e-Med 2010
Materias:
Focus on: Thoracic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967138/
https://www.ncbi.nlm.nih.gov/pubmed/20880782
http://dx.doi.org/10.1102/1470-7330.2010.9029
_version_ 1782189655580475392
author Lin, C.
Itti, E.
Luciani, A.
Haioun, C.
Meignan, M.
Rahmouni, A.
author_facet Lin, C.
Itti, E.
Luciani, A.
Haioun, C.
Meignan, M.
Rahmouni, A.
author_sort Lin, C.
collection PubMed
description The current evidence regarding the usefulness of whole-body diffusion-weighted magnetic resonance imaging (DWI) in lymphoma is reviewed. DWI is capable of combining anatomical and functional information and is becoming a valuable tool in oncology, in particular for staging purposes. DWI may prove to be a useful biomarker in clinical decision making for patients with lymphoma. Large-scaled prospective studies are needed to confirm these preliminary results.
format Text
id pubmed-2967138
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher e-Med
record_format MEDLINE/PubMed
spelling pubmed-29671382012-09-29 Whole-body diffusion-weighted imaging in lymphoma Lin, C. Itti, E. Luciani, A. Haioun, C. Meignan, M. Rahmouni, A. Cancer Imaging Focus on: Thoracic The current evidence regarding the usefulness of whole-body diffusion-weighted magnetic resonance imaging (DWI) in lymphoma is reviewed. DWI is capable of combining anatomical and functional information and is becoming a valuable tool in oncology, in particular for staging purposes. DWI may prove to be a useful biomarker in clinical decision making for patients with lymphoma. Large-scaled prospective studies are needed to confirm these preliminary results. e-Med 2010-09-29 /pmc/articles/PMC2967138/ /pubmed/20880782 http://dx.doi.org/10.1102/1470-7330.2010.9029 Text en © 2010 International Cancer Imaging Society
spellingShingle Focus on: Thoracic
Lin, C.
Itti, E.
Luciani, A.
Haioun, C.
Meignan, M.
Rahmouni, A.
Whole-body diffusion-weighted imaging in lymphoma
title Whole-body diffusion-weighted imaging in lymphoma
title_full Whole-body diffusion-weighted imaging in lymphoma
title_fullStr Whole-body diffusion-weighted imaging in lymphoma
title_full_unstemmed Whole-body diffusion-weighted imaging in lymphoma
title_short Whole-body diffusion-weighted imaging in lymphoma
title_sort whole-body diffusion-weighted imaging in lymphoma
topic Focus on: Thoracic
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967138/
https://www.ncbi.nlm.nih.gov/pubmed/20880782
http://dx.doi.org/10.1102/1470-7330.2010.9029
work_keys_str_mv AT linc wholebodydiffusionweightedimaginginlymphoma
AT ittie wholebodydiffusionweightedimaginginlymphoma
AT luciania wholebodydiffusionweightedimaginginlymphoma
AT haiounc wholebodydiffusionweightedimaginginlymphoma
AT meignanm wholebodydiffusionweightedimaginginlymphoma
AT rahmounia wholebodydiffusionweightedimaginginlymphoma

Ejemplares similares